![Alison Finger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Finger
Direktor/Vorstandsmitglied bei
ADMA BIOLOGICS, INC.
Vermögen: 278 733 $ am 31.05.2026
Profil
Alison C.
Finger currently serves as an Independent Director at ADMA Biologics, Inc. since 2023 and as an Independent Director at KeifeRx LLC.
Former positions include Director at Pharmaceutical Industry Working Group, Managing Director at Bristol-Myers Squibb (NZ) Ltd., Independent Non-Executive Director at Vascular Biogenics Ltd. from 2021 to 2022, Managing Director at Bristol-Myers Squibb Australia Pty Ltd. from 2007 to 2009, Director at Medicines Australia, Director at Alliance for Regenerative Medicine, Director at Regenerative Medicine Foundation, Independent Director at Decibel Therapeutics, Inc. from 2021 to 2023, Chief Commercial Officer at Genetix Biotherapeutics, Inc. from 2015 to 2021, and VP-Global Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2009 to 2014.
Education includes undergraduate studies at St. Lawrence University and an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADMA BIOLOGICS, INC. 0.02% | 31.03.2026 | 34’929 ( 0.02% ) | 278 733 $ | 31.05.2026 |
Aktive Positionen von Alison Finger
| Unternehmen | Position | Beginn |
|---|---|---|
| ADMA BIOLOGICS, INC. | Direktor/Vorstandsmitglied | 28.09.2023 |
KeifeRx LLC
 KeifeRx LLC BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops tyrosine kinase inhibitors to treat neurodegenerative diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Alison Finger
| Unternehmen | Position | Ende |
|---|---|---|
| DECIBEL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 22.09.2023 |
| NOTABLE LABS, LTD. | Direktor/Vorstandsmitglied | 01.08.2022 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2021 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.05.2014 |
Bristol-Myers Squibb Australia Pty Ltd.
 Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops and markets biopharmaceutical medicines | Vorstandsvorsitzender | 01.01.2009 |
Ausbildung von Alison Finger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Bristol-Myers Squibb Australia Pty Ltd.
Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops and markets biopharmaceutical medicines | Health Technology |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Pharmaceutical Industry Working Group | |
Regenerative Medicine Foundation
 Regenerative Medicine Foundation Medical SpecialtiesHealth Technology Develops therapies for disease and translate | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Bristol-Myers Squibb (NZ) Ltd. | |
KeifeRx LLC
KeifeRx LLC BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops tyrosine kinase inhibitors to treat neurodegenerative diseases | Health Technology |
